The Terrifying Psychology of Elizabeth Holmes & Theranos

About this psychology article

She lowered her voice by an octave, wore Steve Jobs' turtleneck, and convinced a board full of powerful, experienced people to hand her hundreds of millions of dollars for technology that never wor...

Board members included two former U.S. Secretaries of State, a former Secretary of Defense, and a retired four-star admiral. The company was valued at nine billion dollars at its peak. And the core technology, a machine that could supposedly run hundreds of tests on a single drop of blood, never actually worked the way it was represented to investors, regulators, or the patients whose real medical decisions depended on its results.

Elizabeth Holmes founded Theranos in 2003, dropped out of Stanford to run it full-time, and spent the next decade and a half convincing an extraordinary number of accomplished, experienced, professionally skeptical people that she had built something she hadn't. In January 2022, a federal jury convicted her on four counts of fraud. The specific legal and business details of the Theranos collapse have been covered extensively elsewhere, most thoroughly in journalist John Carreyrou's investigative reporting and his book Bad Blood . What's worth examining separately is the psychological question underneath the business story: how does someone build, and sustain for over a decade, that specific kind of unshakeable conviction, and what does the research on confidence, charisma, and self-deception actually tell us about how so many capable people believed it?

A Necessary Note on What This Article Is and Isn't Doing

Before going further, it's worth being explicit about something. This article isn't offering a clinical diagnosis of Elizabeth Holmes, and it wouldn't be responsible to do so. Diagnosing a real person from a distance, based on media coverage and courtroom testimony rather than direct clinical evaluation, isn't something any credible psychologist would do, and it isn't something this piece is attempting either. What follows instead is an examination of well-documented psychological research, on confidence, deception, groupthink, and charismatic influence, using Holmes's extensively publicly documented case as a real-world illustration of how these mechanisms actually operate, not as the basis for assigning her a specific diagnosis she has never received from a qualified clinician.

The Documented Behaviors, Not the Diagnosis

Several specific, well-documented details from Carreyrou's reporting and subsequent courtroom testimony are worth naming directly, because they illustrate real psychological mechanisms clearly. Holmes was widely reported, including by former employees who testified under oath, to speak in an unusually low, deep voice that several people who knew her personally stated was not her natural speaking voice. She was known to wear black turtlenecks consistently, a stylistic choice repeatedly and explicitly compared to Steve Jobs, whom she has cited as an influence. Court testimony from former Theranos employees described a workplace culture of extreme secrecy, aggressive non-disclosure agreements, and swift termination for employees who raised concerns about the technology's actual accuracy.

None of these details alone constitute a diagnosis of anything. They're documented choices and documented outcomes. What they offer, examined through the lens of established psychological research rather than speculation, is a genuinely useful case study in exactly how conviction, self-presentation, and organizational pressure can combine to produce sustained, large-scale belief in something that empirical reality didn't support.

What Research on Confident Self-Presentation Actually Shows

Psychologist Cameron Anderson's research on the relationship between confidence and perceived competence offers one relevant thread here. Anderson's studies have repeatedly found that people reliably confuse displayed confidence with actual competence, particularly in situations involving genuine uncertainty, exactly the conditions present when sophisticated investors were evaluating a genuinely novel, technically complex medical technology they couldn't fully verify themselves. This isn't a flaw limited to naive or inexperienced observers. Anderson's research found this confusion persists even among people specifically trained to evaluate expertise, because confident behavior itself functions as a powerful, if unreliable, signal that gets processed largely automatically, well before any careful, deliberate evaluation of the underlying substance occurs.

This connects to the mechanism explored in How the Dark Triad Is Measured , where researchers have documented that traits associated with confident, socially dominant self-presentation are, across multiple studies, disproportionately common among startup founders and business leaders in high-stakes, high-uncertainty environments specifically, environments where displayed conviction is difficult for outside evaluators to independently verify in the short term.

Was It Deception, or Self-Deception? The Distinction the Trial Actually Turned On

This question sits at the exact center of the actual criminal case, and it's worth taking seriously rather than assuming an obvious answer. As explored in The Science of Self-Deception , genuine self-deception, believing your own favorable but inaccurate narrative, is psychologically distinct from calculated, knowing deception of others, even though both can produce nearly identical outward behavior. Holmes's own defense during trial specifically argued a version of the self-deception position, that she genuinely believed in Theranos's technology and its eventual potential, even as specific results were allegedly being manipulated by others within the company without her full knowledge.

The jury's actual verdict is genuinely instructive here, precisely because it didn't fully accept either extreme framing. Holmes was convicted on four counts specifically related to defrauding investors, but was acquitted on charges related to defrauding patients, with the jury reportedly finding the evidence of clear, knowing intent to deceive patients specifically less convincing than the evidence regarding investors. This split verdict suggests something more psychologically nuanced than a simple, one-dimensional con: a scenario where genuine, perhaps partially self-deceived belief in the company's ultimate potential may have coexisted, at different points and toward different audiences, with specific, documented instances of knowing misrepresentation, exactly the kind of uncomfortable middle ground that pure deception or pure self-deception narratives, taken in isolation, tend to flatten into something simpler than the actual verdict, and the actual research on how these mechanisms genuinely operate, would support.

How an Entire Board of Experienced People Missed This

This is arguably the more unsettling part of the story, and it has less to do with Holmes individually than with well-documented group psychology. Psychologist Irving Janis's classic research on groupthink, developed initially through analysis of major foreign policy failures, identified specific conditions under which highly capable groups collectively suppress doubt and converge on a shared, insufficiently examined belief: high group cohesion, insulation from outside expert opinion, and strong, directive leadership that discourages dissent.

Theranos's board and investor structure documented several of these conditions directly. Carreyrou's reporting describes a board composed disproportionately of former government and military figures with limited direct expertise in laboratory science or medical device development, insulated in part from the kind of technical due diligence a board with deeper scientific expertise might have insisted on. This connects to the pattern explored in The Halo Effect Explained : a founder's impressive résumé, Stanford credentials, an articulate and compelling personal narrative, and a genuinely charismatic presence appear, across documented board testimony, to have generated broad, insufficiently examined confidence in domains, specifically the underlying laboratory science, that these particular qualities don't actually verify at all.

Why Employees Who Raised Concerns Were Pushed Out

Multiple former Theranos employees testified, under oath, to a workplace culture where raising technical concerns about the blood-testing technology's accuracy led directly to termination or systematic exclusion. This pattern connects directly to psychologist Amy Edmondson's extensive research on psychological safety in organizations, which has consistently found that when employees don't feel safe raising concerns without risk of punishment, organizations lose access to exactly the early-warning information most capable of catching serious problems before they compound into large-scale failure.

This is closely related to the mechanism explored in The Psychology of Obedience : a hierarchical culture that actively punishes dissent doesn't just silence individual objections. It can shift how each person present experiences their own responsibility for what the organization does collectively, redistributing accountability upward toward leadership in a way that can make continued participation in a compromised process feel less like an active personal choice and more like simply following an established, sanctioned direction.

What This Case Actually Reveals About Charismatic Deception

Psychologist Robert Cialdini's research on the principle of authority, part of his broader, extensively studied framework on influence and persuasion, offers a useful lens for understanding how Holmes's specific self-presentation choices functioned. Deliberately deep vocal register, distinctive personal styling directly associated with an already-legendary tech figure, an unwavering, unhesitating manner of speaking about the technology's capabilities: each of these details functioned as what Cialdini's research would classify as an authority cue, a signal that triggers deference somewhat independently of the actual underlying substance being evaluated.

None of these signals, individually or combined, constitute actual evidence that a blood-testing device works. But Cialdini's decades of research consistently demonstrate that authority cues process largely automatically, triggering trust and reduced scrutiny before a more careful, deliberate evaluation has fully occurred, exactly the gap that allowed a technology later proven in court to be fundamentally non-functional to secure a nine-billion-dollar valuation from people with every professional incentive and considerable expertise to look more closely.

The Belief That Made the Deception Sustainable for So Long

Underneath a story like this sits a specific, quiet dynamic worth naming directly: once enormous financial, reputational, and personal investment has already been made in a narrative, walking it back becomes progressively more costly, for the person maintaining the narrative and for everyone who has already publicly backed it. This connects to the mechanism explored in The Sunk Cost Fallacy Explained : the later stages of the Theranos story appear, based on the reporting and trial testimony, to have involved not just an initial deception or self-deception, but an accumulating structural pressure where each subsequent stage of the story became progressively harder to abandon, precisely because so much prior credibility, and so many other people's reputations and money, were already tied to it continuing.

What This Case Is Not

This case isn't primarily a story about a single, unusually manipulative individual succeeding through personal traits found nowhere else. It's a documented, extensively verified illustration of well-established psychological mechanisms, confidence-competence confusion, groupthink, authority signaling, and the accumulating pressure of sunk-cost investment, operating together, at scale, against people with genuine expertise and every institutional incentive to catch the problem earlier than they did. Understanding it this way is more useful, and considerably more unsettling in the most productive sense, than treating Holmes as a singular, uniquely evil outlier. The actual research suggests these mechanisms are common enough, and powerful enough, that recognizing the pattern matters considerably more than assuming you'd obviously be immune to it.

See Your Own Vulnerability to These Patterns More Clearly

Reading about a well-documented case is different from recognizing how confidence, authority, and charismatic self-presentation actually influence your own judgment and decision-making.

→ Take the Manipulation Detection Assessment

Free. No account required.

Curious how your own decision-making style holds up under pressure, uncertainty, and persuasive authority?

→ Explore the Decision-Making Style Test in the PsychOS Assessment Lab

Frequently Asked Questions

Was Elizabeth Holmes diagnosed with a personality disorder?

No formal clinical diagnosis has been made public, and this article deliberately avoids diagnosing her. It instead examines well-documented psychological research on confidence, deception, and group dynamics, using her extensively publicly reported case as an illustrative example.

Did Elizabeth Holmes know Theranos's technology didn't work?

The jury's actual verdict was more nuanced than a simple yes or no. She was convicted on counts related to defrauding investors but acquitted on charges related to defrauding patients, suggesting the evidence supported knowing deception in some contexts more clearly than others.

How did an experienced board fail to catch this?

Research on groupthink identifies specific conditions, high group cohesion, insulation from outside technical expertise, and strong directive leadership discouraging dissent, that can cause even highly capable groups to collectively underexamine a shared belief, conditions well documented in Theranos's board structure.

Why does confident behavior convince people so effectively?

Research by psychologist Cameron Anderson has found that people consistently confuse displayed confidence with actual competence, particularly under genuine uncertainty, and this confusion persists even among trained evaluators, because confidence functions as an automatic signal processed before careful evaluation occurs.

What's the main psychological lesson from the Theranos case?

That well-documented, common psychological mechanisms, not a rare, singular type of manipulator, can combine to produce sustained large-scale deception, which means recognizing these mechanisms in general is more useful than assuming any one person is simply uniquely dangerous.

Want to see how PsychOS handles psychology research, sources, limitations, and interpretation? Read Editorial Standards